Literature DB >> 26369016

Polyethylene Sebacate-Silymarin Nanoparticles with Enhanced Hepatoprotective Activity.

Swati A Guhagarkar, Devang Shah, Mitesh D Patel, Sadhana S Sathaye, Padma V Devarajan.   

Abstract

The present study evaluates role of pullulan as hepatic targeting agent. Nanoparticles of silymarin (SIM) a hepatoprotective drug were prepared using polyethylene sebacate (PES) as biodegradable polymer and surface modified with pullulan. PES-SIM nanoparticles (PES-SIM NP) and PES-SIM nanoparticles surface modified with pullulan (PES-SIM-PUL) were prepared by nanoprecipitation. Nanoparticles were evaluated for hepatoprotective activity in a model of carbon-tetrachloride (CCl4) induced hepatotoxicity in rats. Pretreatment of rats with PES-SIM-NP and PES-SIM-PUL revealed reduced levels of SGOT, SGPT and ALKP compared to CCl4 treated group (p < 0.01) whereas levels of LPO and catalase were comparable to vehicle control suggesting enhanced hepatoprotection with nanoparticles. Histopathological evaluation of liver tissues also revealed better hepatoprotection with nanoparticles. Further significant decrease (p < 0.01) in levels of SGOT, SGPT and ALKP with difference PES-SIM-PUL than PES-SIM NP confirms the role of pullulan as hepatic targeting agent.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26369016     DOI: 10.1166/jnn.2015.9518

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  2 in total

Review 1.  Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art.

Authors:  Alfonso Di Costanzo; Ruggero Angelico
Journal:  Molecules       Date:  2019-06-07       Impact factor: 4.411

2.  Fabrication and evaluation of mannose decorated curcumin loaded nanostructured lipid carriers for hepatocyte targeting: In vivo hepatoprotective activity in Wistar rats.

Authors:  Manish Kumar Gupta; Vipul Sansare; Birendra Shrivastava; Santosh Jadhav; Prashant Gurav
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-01-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.